Literature DB >> 6180044

Platelet-derived growth factor (PDGF) inhibits antiviral and anticellular actin of interferon in synchronized mouse or human cells.

E Oleszak, A D Inglot.   

Abstract

Antiviral and anticellular action of purified mouse or human interferon was found to be inhibited in the quiescent, monolayer cultures of mouse or human fibroblasts (3T3 and FS-14) stimulated for growth by PDGF. In the asynchronous cell cultures the antagonistic effect of PDGF towards interferon, was much less evident. The optimal synchronization of cells for division was obtained by density inhibition and the incubation of the confluent cell monolayers in the low serum medium for 24 h and in 5% platelet poor plasma serum (PPPS) medium for further 24 h at 37 degrees C. Under appropriate conditions also pure epidermal growth factor (EGF) and fibroblast growth factor (FGF) acted as antagonists of interferon. It is suggested that interferons and growth factors are two families of hormones. The effects induced by interferons and growth factors are found to be directly opposite.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6180044     DOI: 10.1089/jir.1980.1.37

Source DB:  PubMed          Journal:  J Interferon Res        ISSN: 0197-8357


  4 in total

Review 1.  The hormonal concept of interferon. Brief review.

Authors:  A D Inglot
Journal:  Arch Virol       Date:  1983       Impact factor: 2.574

2.  Interferon increases the abundance of submembranous microfilaments in HeLa-S3 cells in suspension culture.

Authors:  E Wang; L M Pfeffer; I Tamm
Journal:  Proc Natl Acad Sci U S A       Date:  1981-10       Impact factor: 11.205

3.  A cytokine network in human diploid fibroblasts: interactions of beta-interferons, tumor necrosis factor, platelet-derived growth factor, and interleukin-1.

Authors:  M Kohase; L T May; I Tamm; J Vilcek; P B Sehgal
Journal:  Mol Cell Biol       Date:  1987-01       Impact factor: 4.272

4.  Inhibition of mitogen stimulated growth of human colon cancer cells by interferon.

Authors:  A W Hamburger; M E Condon; K O'Donnell
Journal:  Br J Cancer       Date:  1988-08       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.